Publications by authors named "M Tsereteli"
Exposure to healthcare procedures might be a source of hepatitis C virus (HCV) transmission in Georgia, one of the few countries currently on track to eliminate hepatitis C. While there has been a history of iatrogenic transmission of HCV, the risk of HCV transmission related to endoscopic procedures has not been previously assessed in Georgia. The goal of this study was to assess HCV seroconversion among individuals undergoing endoscopic procedures to estimate the relative role and incidence of HCV infection attributable to endoscopic procedures.
View Article and Find Full Text PDFA nationwide serosurvey among adults in 2021 showed a 2.7% (95% confidence interval [CI]: 2.3%-3.
View Article and Find Full Text PDFBackground: Hepatitis C virus (HCV) infection can lead to a type of primary liver cancer called hepatocellular carcinoma (HCC). Georgia, a high HCV prevalence country, started an HCV elimination program in 2015. In addition to tracking incidence and mortality, surveillance for the HCV-attributable fraction of HCC is an important indicator of the program's impact.
View Article and Find Full Text PDFArticle Synopsis
- * Researchers assessed infection control practices and testing methods across 27 dialysis centers in Georgia during a facility-based survey conducted from April to June 2021.
- * Findings revealed significant gaps in infection control, with a notable number of patients seroconverting for both HCV and HBV, indicating a need for stricter adherence to safety protocols to minimize transmission risks.
Hepatitis B and hepatitis C are leading causes of cirrhosis and liver cancer and caused 1.3 million deaths worldwide in 2022. Hepatitis B is preventable with vaccination, and hepatitis C is curable with direct-acting antivirals.
View Article and Find Full Text PDF